Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 02/02/19981 min de lecture
Developing Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring; Public Meeting
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing a public meeting entitled ``Developing Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring.'' The purpose of the public meeting is to provide a forum for FDA to gather information for the development of new regulations for the review of radiopharmaceutical applications as required by the Food and Drug Administration Modernization Act of 1997 (the FDAMA).
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →